What Has Been the Growth Trajectory for the Computational Biology Market in Recent Years?
The computational biology market has seen considerable growth due to a variety of factors.
• The market size of computational biology has experienced significant growth in the recent past. The market is projected to expand from $8.09 billion in 2024 to $9.52 billion in 2025, with a compound annual growth rate (CAGR) of 17.6%.
Factors driving this increase during the historical period include the integration of multi-omics, advances in personalized medicine and precision healthcare, the revolution in genomic sequencing, and the management of biological big data.
How Does the Forecast Look for the Computational Biology Market?
The computational biology market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the computational biology market is projected to experience dramatic expansion in the upcoming years, reaching a valuation of $22.47 billion in 2029, a result of a compound annual growth rate (CAGR) of 23.9%.
The surge in growth during this projected period can be credited to the rise in cloud computing, high-performance computing (HPC), the increasing use of quantitative and predictive biology, interdisciplinary research collaborations, and advancements in both bioinformatics and computational tools. Key trends anticipated during this prediction period encompass advances in bioinformatics and data science, genomic sequencing technologies, the application of machine learning and AI in bioinformatics, advancements in drug discovery and development, and strides in personalized medicine and precision healthcare.
What Are The Leading Drivers Of Growth In The Computational Biology Market?
The computational biology market has primarily been propelled by government funding. Worldwide, governments are injecting capital into infrastructure and academia to bolster the capabilities of computational biologics across R&D, educational entities, and additional sectors. This swift escalation of government funding is anticipated to stimulate demand for computational biology solutions, given their broad application in R&D, clinical research, and other progression initiatives. For example, in April 2023, The National Cancer Institute (NCI), an American governmental agency, had a total budget of $6.4 billion, inclusive of $195 million received through the CURES Act. This amounted to a 1.6 percent increase, equivalent to $99.3 million, relative to the prior fiscal year. Thus, government funding is the motor propelling the computational biology market's growth.
How Are The Segments Defined Within The Global Computational Biology Market?
The computational biology market covered in this report is segmented –
1) By Services: In-house, Contract
2) By Tools: Databases, Infrastructure (Hardware), Analysis Software and Services
3) By Application: Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Clinical Trials
4) By End Users: Research, Pharmaceutical Industry, Commercial Applications
Subsegments:
1) By In-house: Data Analysis, Software Development, Research And Development
2) By Contract: Outsourced Bioinformatics, Collaborative Research, Data Management Services
Pre-Book The Computational Biology Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Computational Biology Market?
Leading firms in the computational biology market are focusing on the formulation of new solutions to enhance proteomics research and stay competitive. Proteomics research primarily involves comprehensive studies of proteins within biological systems. For example, in May 2023, Biognosys AG, a biotech company from Switzerland, introduced Spectronaut 18 and made substantial scientific and technical advancements in its proprietary software and products for proteomics research. Spectronaut 18 enables high efficiency and throughput in DIA proteomics analysis. The TrueDiscovery platform developed by the company expedites biomarker identification in areas like oncology and neuroscience, offering exceptional depth and sensitivity in proteomics. TrueTarget facilitates precise drug target identification and deconvolution, and the company's iRT Kit, suitable for real-time system applicability monitoring, is now compatible with Bruker ProteoScape software.
Who Are the Key Players in the Computational Biology Market?
Major companies operating in the computational biology market include:
• Certara L. P
• Chemical Computing Group Inc.
• Compugen Ltd.
• Genedata AG
• Insilico Biotechnology AG
• Dassault Systèmes SE
• Instem PLC
• Rosa & Co. LLC
• Simulation Plus Inc.
• Nimbus Discovery LLC
• Rhenovia Pharma SAS
• Leadscope Inc.
• DNAnexus
• Altaris Capital Partner
• Genialis Inc.
• Inari Agriculture Inc.
• BC Platforms
• Ventus Therapeutics
• Monte Rosa Therapeutics
• Schrodinger Inc.
• Strand Life Sciences
• Entos Pharmaceuticals
• Numerate Inc.
• Insitro
• Recursion Pharmaceuticals
• Atomwise
• Relay Therapeutics
• Exscientia
What Is The Most Dominant Region In The Computational Biology Market?
North America was the largest region in the computational biology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computational biology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
